Zidovudine
What is Zidovudine?
Zidovudine (CAS 30516-87-1), also known as AZT and marketed as Retrovir®, is an antiretroviral nucleoside analogue used as an active pharmaceutical ingredient in HIV treatment formulations.
Where is Zidovudine used?
- Pharmaceutical industry: API in oral solid and liquid dosage forms such as tablets, capsules and syrups for HIV/AIDS treatment protocols
- Fixed-dose combination products: blended with other antiretrovirals under compatibility assessment
- Combination drug substance synthesis: intermediate subject to regulatory review and quality control
- Research institutions and generic drug developers use it as a reference standard or starting material for bioequivalence and stability studies.
Good to know: It functions as a reverse transcriptase inhibitor, blocking viral replication at the enzymatic level. Not to be confused with other nucleoside analogues.
Commercial specifications
- Quantities from research-scale to commercial bulk
- Full batch documentation for regulated-market buyers
Other Names (Synonyms)
Zidovudin|Retrovir®|AZT|3'-azido-3'-deoxythymidine|ZDV|Thymidine, 3'-azido-3'-deoxy-|Compound S|BW A509U